Location of Repository

The Role of Hyperoxia in Abnormal Development of Fetal Lung.

By Porus C. Bustani
Publisher: University of Leicester
Year: 2007
OAI identifier: oai:lra.le.ac.uk:2381/4567

Suggested articles



  1. A controlled trial of dexamethasone in preterm infants at high risk for bronchopulmonary dysplasia.
  2. A direct requirement of nuclear factor-kappa B for suppression of apoptosis in ventricular myocytes.
  3. (1987). Adaptation to chronic hyperoxia. Biochemical effects and the response to subsequent lethal hyperoxia. Am Rev Respir Dis
  4. Adjustment of arterial blood gases and acid base balance in the normal newborn infant during the first week of life. Biol Neonat JT -Biologia neonatorum. Neo-natal studies.
  5. An endotoxininduced serum factor that causes necrosis of tumors.
  6. An essential role for free radicals and derived species in signal transduction.
  7. Angiogenesis driving alveolisation: the role of PECAM-1 in alveolar septation.
  8. (1972). Antenatal corticosteroid therapy: a meta-analysis of the randomized trials,
  9. Antenatal infection/inflammation and postnatal lung maturation and injury.
  10. Antineutrophil chemokine preserves alveolar development in hyperoxia-exposed newborn rats.
  11. Apoptosis and cell proliferation potential of bovine embryos stimulated with insulin-like growth factor I during in vitro maturation and culture.
  12. Apoptosis and proliferation in lungs of ventilated and oxygen-treated preterm infants.
  13. Apoptosis in lung development and neonatal lung injury.
  14. (1998). Apoptosis in the development of rat and human fetal lungs.
  15. Apoptosis in various organs of preterm infants: histopathologic study of lung, kidney, liver, and brain of ventilated infants.
  16. (1997). Augmented intracellular glutathione inhibits Fas-triggered apoptosis of activated human neutrophils.
  17. Basic fibroblast growth factor accelerates gastric mucosal restoration in vitro by promoting mesenchymal cell migration and proliferation.
  18. Blocking neutrophil influx reduces DNA damage in hyperoxia-exposed newborn rat lung.
  19. Broad-spectrum antibiotics for preterm, prelabour rupture of fetal membranes: the ORACLE I randomised trial.
  20. Broad-spectrum antibiotics for spontaneous preterm labour: the ORACLE II randomised trial.
  21. Bronchopulmonary dysplasia and oxidative stress: are we closer to an understanding of the pathogenesis of BPD?
  22. (1984). Bronchopulmonary dysplasia: a morphometric study with emphasis on the pulmonary vasculature. Pediatr Pathol
  23. (1999). Caspases in developmental cell death.
  24. Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67.
  25. (1987). Cell injury and adaptation.
  26. Cellular distribution and relative amounts of vascular endothelium growth factor mRNA in granulosa cells from human preovulatory follicles.
  27. Chemokine signaling in inflammation.
  28. Chronic lung disease of prematurity: clinical and pathophysiological correlates.
  29. (1996). Clinical surfactant preparations mediate SOD and catalase uptake by type II cells and lung tissue.
  30. Clinical trial of vitamin A supplementation in infants susceptible to bronchopulmonary dysplasia.
  31. (1996). Collagen VI regulates normal and transformed mesenchymal cell proliferation in vitro. Exp Cell Res
  32. (1990). Colocalization of TGF-beta 1 and collagen I and III, fibronectin and glycosaminoglycans during lung branching morphogenesis.
  33. (1990). Correlation of free oxygen radicalinduced lipid peroxidation with outcome in very low birth weight infants.
  34. (1995). Cromolyn inhibits assembly of the NADPH oxidase and superoxide anion generation by human neutrophils.
  35. (1997). Cromolyn sodium prophylaxis inhibits pulmonary proinflammatory cytokines in infants at high risk for bronchopulmonary dysplasia.
  36. Cyclic mechanical stretch inhibits cell proliferation and induces apoptosis in fetal rat lung fibroblasts.
  37. (2004). Cytokines Online Pathfinder Encyclopaedia.
  38. (2001). Delayed (>3 weeks) postnatal corticosteroids for chronic lung disease in preterm infants. Cochrane Database Syst Rev
  39. (1992). Developing bronchopulmonary epithelium of the human fetus secretes fluid.
  40. Development of human fetal lung in organ culture compared with in utero ontogeny.
  41. Developmental aspects of experimental pulmonary oxygen toxicity. Free Radic Biol Med JT - Free radical biology &
  42. (1994). Different signal transduction properties of KDR and Flt1, two receptors for vascular endothelial growth factor.
  43. (1996). Differential release of prostaglandins by organ cultures of human fetal trachea and lung.
  44. Differentiation of type II cells of human fetal lung in vitro.
  45. Differentiation-arrested rat fetal lung in primary monolayer cell culture. IV. Paradoxical effect of a "fetal" pO2 on precursor incorporation into phospholipids and hormone responsiveness.
  46. (2000). Early administration of inhaled corticosteroids for preventing chronic lung disease in ventilated very low birth weight preterm neonates. Cochrane Database Syst Rev
  47. (2000). Early postnatal (<96 hours) corticosteroids for preventing chronic lung disease in preterm infants. Cochrane Database Syst Rev
  48. (1995). Effect of IL-1 blockade on inflammatory manifestations of acute ventilator-induced lung injury in a rabbit model. Exp Lung Res
  49. Effect of serum and cell density on transmembrane distribution of cAMP and cGMP in transformed (C4-I) and non-transformed (WI-38) human cells.
  50. Effect of type I collagen on the adhesion, proliferation, and osteoblastic gene expression of bone marrowderived mesenchymal stem cells.
  51. Effects of adrenaline and of spontaneous labour on the secretion and absorption of lung liquid in the fetal lamb.
  52. (1997). Effects of antenatal and postnatal corticosteroids on the preterm lung. Arch Dis Child Fetal Neonatal Ed
  53. (2000). Effects of early inhaled beclomethasone therapy on tracheal aspirate inflammatory mediators IL-8 and IL-1ra in ventilated preterm infants at risk for bronchopulmonary dysplasia. Pediatr Pulmonol
  54. (2003). Effects of hyperoxia on VEGF, its receptors and HIF2alpha in the newborn rat lung.
  55. (1980). Effects of inspired oxygen on echocardiographic assessment of pulmonary vascular resistance and myocardial contractility in bronchopulmonary dysplasia. Pediatrics JT - Pediatrics.
  56. (1998). Effects of mesenchyme on epithelial tissue architecture revealed by tissue recombination experiments between the submandibular gland and lung of embryonic mice.
  57. (1996). Elevated cytokine levels in tracheobronchial aspirate fluids from ventilator treated neonates with bronchopulmonary dysplasia.
  58. (1996). Eliminating sleep-associated hypoxemia improves growth in infants with bronchopulmonary dysplasia. Pediatrics JT - Pediatrics.
  59. (1996). Epidermal growth factor, but not hepatocyte growth factor, suppresses the apoptosis induced by transforming growth factor-beta in fetal hepatocytes in primary culture.
  60. Epithelial cell differentiation in organotypic cultures of fetal rat lung.
  61. (1997). Epithelial morphogenesis in mouse embryonic submandibular gland: its relationships to the tissue organization of epithelium and mesenchyme. Dev Growth Differ
  62. Epithelial-mesenchymal interaction during lung development: the effect of mesenchymal mass.
  63. (2003). Erythromycin for the prevention of chronic lung disease in intubated preterm infants at risk for, or colonized or infected with Ureaplasma urealyticum. Cochrane Database Syst Rev JT - Cochrane database of systematic reviews (Online)
  64. (1997). Execution mechanisms of programmed cell death by caspase (ICE/CED-3) family proteases. Heart Vessels
  65. Experimental models of bronchopulmonary dysplasia.
  66. (1998). Expression and developmental profile of antioxidant enzymes in human lung and liver.
  67. (1993). Failure of cromolyn sodium to reduce the incidence of bronchopulmonary dysplasia: a pilot study. The Neonatal Cromolyn Study Group. Pediatrics
  68. (1991). Failure of premature rabbits to increase antioxidant enzymes during hyperoxic exposure: increased susceptibility to pulmonary oxygen toxicity compared with term rabbits. Pediatr Res
  69. (1991). Failure of supplementation with vitamin E to prevent bronchopulmonary dysplasia in infants less than 1,500 g birth weight.
  70. (1996). Fibroblast growth factor-2 stimulates embryonic cardiac mesenchymal cell proliferation. Dev Dyn
  71. (1992). Formation of alveoli in rats: postnatal effect of prenatal dexamethasone.
  72. (1998). Functional and pathological effects of prolonged hyperoxia in neonatal mice.
  73. Functional differentiation of alveolar type II epithelial cells in vitro: effects of cell shape, cell-matrix interactions and cellcell interactions.
  74. (1990). Growth and differentiation of human distal airway epithelial cells in culture. Effects of small amounts of serum in defined medium.
  75. (1993). High affinity VEGF binding and developmental expression suggest Flk-1 as a major regulator of vasculogenesis and angiogenesis.
  76. (1960). Home oxygen promotes weight gain in infants with bronchopulmonary dysplasia.
  77. (1997). Human chemokines: an update. Annu Rev Immunol
  78. Human vascular permeability factor. Isolation from U937 cells.
  79. Hyperoxia increases keratinocyte growth factor mRNA expression in neonatal rabbit lung.
  80. Hyperoxia inhibits oxidant-induced apoptosis in lung epithelial cells.
  81. (1992). Hypoxia/reoxygenation stimulates endothelium to promote neutrophil adhesion. Free Radic Biol Med
  82. (1994). Hypoxic stimulation of vascular endothelial growth factor expression in vitro and in vivo.
  83. Ibuprofen affects pro- and antiinflammatory cytokine production by mononuclear cells of preterm newborns.
  84. Ibuprofen use to reduce the incidence and severity of bronchopulmonary dysplasia: a pilot study.
  85. (1992). Identification of the KDR tyrosine kinase as a receptor for vascular endothelial cell growth factor.
  86. (1997). IL-10 improves lung injury and survival in Pseudomonas aeruginosa pneumonia.
  87. IL-13 stimulates vascular endothelial cell growth factor and protects against hyperoxic acute lung injury.
  88. (2000). Improved pulmonary outcome at one year corrected age in premature neonates treated with recombinant human superoxide dismutase. Pediatr Res
  89. (1998). Increased endothelial cell expression of platelet-endothelial cell adhesion molecule-1 during hyperoxic lung injury.
  90. Increased epithelial cell proliferation in very premature baboons with chronic lung disease.
  91. Increased expression of Apaf-1 and procaspase-3 and the functionality of intrinsic apoptosis apparatus in nonsmall cell lung carcinoma.
  92. Induced p21Cip1 in premature baboons with CLD: implications for alveolar hypoplasia.
  93. (1999). Induction of alveolar type II cell differentiation in embryonic tracheal epithelium in mesenchyme-free culture.
  94. Induction of bud formation of embryonic mouse tracheal epithelium by fibroblast growth factor plus transferrin in mesenchyme-free culture.
  95. (1998). Induction of p21WAF/CIP1 during hyperoxia.
  96. (1999). Inhaled nitric oxide protects against hyperoxia-induced apoptosis in rat lungs.
  97. Inhibition of angiogenesis decreases alveolarization in the developing rat lung.
  98. (1993). Inhibition of lung inflammatory reactions in rats by an anti-human IL-8 antibody.
  99. Inhibition of macrophage proinflammatory cytokine expression by steroids and recombinant IL-10.
  100. Inhibition of neutrophil and eosinophil induced chemotaxis by nedocromil sodium and sodium cromoglycate.
  101. (1999). Insulin-likegrowth-factor-I (IGF-I) antagonizes apoptosis induced by serum deficiency and doxorubicin in neuronal cell culture.
  102. (1997). Introduction to immunocytochemistry /
  103. Involvement of reactive oxygen intermediates in spontaneous and CD95 (Fas/APO-1)-mediated apoptosis of neutrophils.
  104. (1976). Ion transport and water flow in the mammalian lung. Ciba Found Symp
  105. Ischaemia/reperfusion, inflammatory responses and acute lung injury.
  106. (1996). Keratinocyte growth factor and its receptor are involved in regulating early lung branching.
  107. Keratinocyte growth factor enhances maturation of fetal rat lung type II cells.
  108. (1994). Keratinocyte growth factor is a growth factor for type II pneumocytes in vivo.
  109. (1999). KGF and FGF-10 stimulate liquid secretion in human fetal lung. Pediatr Res
  110. Liposomal antioxidants provide prolonged protection against acute respiratory distress syndrome.
  111. Long-term follow-up of premature infants treated with prophylactic, intratracheal recombinant human CuZn superoxide dismutase.
  112. Luks FI. Fas/FasL-mediated apoptosis in perinatal murine lungs.
  113. (1999). Lung branching morphogenesis: Role of growth factors and extracellular matrix.
  114. (1999). Lung development and pulmonary angiogenesis.
  115. (1999). Lung fibroblasts undergo apoptosis following alveolarization.
  116. Lung growth: implications for the newborn infant.
  117. Lung inflammation in hyperoxia can be prevented by antichemokine treatment in newborn rats.
  118. Lung injury in neonates: Causes, strategies for prevention, and long-term consequences.
  119. Lung liquid production and composition in the &quot;in utero&quot; foetal lamb.
  120. Macromolecular synthesis in organ cultures of neonatal rat lung.
  121. Mechanical ventilation in newborn infants with respiratory railure.
  122. (1998). Mechanisms initiating lung injury in the preterm. Early Hum Dev
  123. (1999). Mechanisms of cell growth and tissue repair.
  124. MEK-1/2 inhibition reduces branching morphogenesis and causes mesenchymal cell apoptosis in fetal rat lungs.
  125. (2000). Moderately early (7-14 days) postnatal corticosteroids for preventing chronic lung disease in preterm infants. Cochrane Database Syst Rev
  126. (1992). Molecular and biological properties of the vascular endothelial growth factor family of proteins. Endocr Rev
  127. (1997). Molecular pharmacology of glucocorticoids.
  128. (1996). Morphogenesis of the lung: control of embryonic and fetal branching. Annu Rev Physiol
  129. Morphologic and biochemical hallmarks of apoptosis.
  130. (1986). Morphologic changes in pulmonary oxygen toxicity. Annu Rev Physiol
  131. Morphometry explains variation in airway responsiveness
  132. Necrotic cell death in response to oxidant stress involves the activation of the apoptogenic caspase-8/bid pathway.
  133. (1999). Neonatal chronic lung disease in extremely immature baboons.
  134. NF-kappaB activation.
  135. (1999). NF-kappaB induces expression of the Bcl-2 homologue A1/Bfl-1 to preferentially suppress chemotherapy-induced apoptosis.
  136. Nitric oxide modulates branching morphogenesis in fetal rat lung explants.
  137. Nonpeptide CXCR2 antagonist prevents neutrophil accumulation in hyperoxiaexposed newborn rats.
  138. (1997). Nuclear factorkappaB is activated by hyperoxia but does not protect from cell death.
  139. (1998). O2 regulates surfactant protein A mRNA transcription and stability in human fetal lung in vitro.
  140. (1998). O2-induced ENaC expression is associated with NF-kappaB activation and blocked by superoxide scavenger.
  141. (1998). Ontogeny of apoptosis during lung development. Pediatr Res
  142. or the quantitative evaluation of microstructures.
  143. (1995). Oxygen modulates surfactant protein mRNA expression and phospholipid production in human fetal lung in vitro.
  144. Oxygen modulates the differentiation of human fetal lung in vitro and its responsiveness to cAMP.
  145. (1991). Oxygen radicals induce human endothelial cells to express GMP-140 and bind neutrophils.
  146. Oxygen regulates mitogen-stimulated proliferation of fetal human airway smooth muscle cells.
  147. Oxygen supply and oxygen-dependent gene expression in differentiating embryonic stem cells.
  148. (1998). Oxygen toxicity in mouse lung: pathways to cell death.
  149. Oxygen toxicity in the newborn. The effect of prolonged 100 per cent O2 exposure on the lungs of newborn mice.
  150. Oxygen-saturation targets and outcomes in extremely preterm infants.
  151. (2000). Pathology of Chronic lung disease in early infancy.
  152. (1975). Postnatal growth and development of the lung. Am Rev Respir Dis
  153. Postnatal growth and function of the pre-acinar airways.
  154. Prediction of survival for preterm births by weight and gestational age: retrospective population based study.
  155. (1992). Prenatal dexamethasone treatment improves survival of newborn rats during prolonged high O2 exposure. Pediatr Res
  156. Prenatal origins of human intrapulmonary arteries: formation and smooth muscle maturation.
  157. Preterm labor, preterm premature rupture of membranes, and chorioamnionitis.
  158. Prevention of bronchopulmonary dysplasia by administration of bovine superoxide dismutase in preterm infants with respiratory distress syndrome.
  159. (1991). Primary culture of adult mouse lung fibroblasts in serum-free medium: responses to growth factors. Exp Cell Res
  160. (1998). Programmed cell death contributes to postnatal lung development.
  161. (2001). Programmed cell death in normal fetal rat lung development. Exp Lung Res
  162. (2002). Programmed cell death. 4th editioned.
  163. (1999). Proliferation and differentiation defects during lung development in corticotropin-releasing hormone-deficient mice.
  164. (1993). Prophylactic effects of recombinant human superoxide dismutase in neonatal lung injury.
  165. Pulmonary disease following respirator therapy of hyaline-membrane disease. Bronchopulmonary dysplasia.
  166. (1985). Pulmonary oxygen toxicity.
  167. (1990). Pulmonary vascular damage and the development of cor pulmonale following hyaline membrane disease. Pediatr Pulmonol
  168. (1985). Pulmonary vascular response to oxygen in infants with severe bronchopulmonary dysplasia. Pediatrics JT - Pediatrics.
  169. (2001). Pulse oximetry, severe retinopathy, and outcome at one year in babies of less than 28 weeks gestation. Arch Dis Child Fetal Neonatal Ed
  170. (1990). Quible DJ. Changes in gene expression in hyperoxia-induced neonatal lung injury.
  171. (1998). Randomised trial of erythromycin on the development of chronic lung disease in preterm infants. Arch Dis Child Fetal Neonatal Ed
  172. Recent increase in mortality from hyaline membrane disease.
  173. (2002). Regulation of cell proliferation by insulin-like growth factor 1 in hyperoxia-exposed neonatal rat lung. Mol Genet Metab
  174. Regulation of epithelial proliferation by TGFbeta. Ciba Found Symp 1991;157:66-74; discussion
  175. (1996). Regulation of fibroblast proliferation in three-dimensional collagen gel matrix.
  176. (1992). Regulation of gene expression by O2 tension.
  177. Retinopathy of prematurity.
  178. Retrolental fibroplasia; cooperative study of retrolental fibroplasia and the use of oxygen.
  179. (2003). Role of Fas-ligand induced apoptosis in pulmonary inflammation and injury. Curr Drug Targets Inflamm Allergy
  180. Role of reactive oxygen species (ROS) in apoptosis induction.
  181. (1995). Role of the Flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium.
  182. Role of xanthine oxidase and granulocytes in ischemia-reperfusion injury.
  183. (2002). Roles for insulin-like growth factor I and transforming growth factor-beta in fibrotic lung disease. Chest
  184. Selective staining with hematoxylin, applications and theory: a review.
  185. (1995). Sequential reduction of mitochondrial transmembrane potential and generation of reactive oxygen species in early programmed cell death.
  186. (1992). Social controls on cell survival and cell death.
  187. (1993). Spontaneous contractility of human fetal airway smooth muscle.
  188. Stem cell factor and stromal cell coculture prevent apoptosis in a subculture of the megakaryoblastic cell line, UT-
  189. Structure-activity relationship study of novel necroptosis inhibitors.
  190. Sudden infant death syndrome in infants with bronchopulmonary dysplasia.
  191. (2001). Superoxide dismutase for preventing chronic lung disease in mechanically ventilated preterm infants. Cochrane Database Syst Rev
  192. Supplemental Therapeutic Oxygen for Prethreshold Retinopathy Of Prematurity (STOP-ROP), a randomized, controlled trial. I: primary outcomes.
  193. Suppression of nuclear factor-kappa B activity by nitric oxide and hyperoxia in oxygen-resistant cells.
  194. TGF-betas synthesized by RPE cells have autocrine activity on mesenchymal transformation and cell proliferation.
  195. (1991). The BPD problem. Pediatrics
  196. The cell : a molecular approach
  197. The cell proliferation-associated antigen of antibody Ki-67: a very large, ubiquitous nuclear protein with numerous repeated elements, representing a new kind of cell cycle-maintaining proteins.
  198. (1998). The development of large and small airways.
  199. (1981). The development of the newborn rat lung in hyperoxia: a dose-response study of lung growth, maturation, and changes in antioxidant enzyme activities. Pediatr Res
  200. (1998). The effects of hyperoxic injury and antioxidant vitamins on death and proliferation of human small airway epithelial cells.
  201. (1987). The effects of preterm delivery and mechanical ventilation on human lung growth. Early Hum Dev
  202. The role of inflammation in the development of chronic lung disease in neonates.
  203. The role of vascular growth factors in hyperoxiainduced injury to the developing lung.
  204. Time-lapse observation of branching morphogenesis of the lung bud epithelium in mesenchyme-free culture and its relationship with the localization of actin filaments.
  205. To die or not to die: an overview of apoptosis and its role in disease.
  206. To live or die: a critical decision for the lung.
  207. Tumor necrosis factor.
  208. (1995). Utility of microwave-citrate antigen retrieval in diagnostic immunohistochemistry. Mod Pathol
  209. (1995). Vascular endothelial growth factor acts as a survival factor for newly formed retinal vessels and has implications for retinopathy of prematurity.
  210. Vascular endothelial growth factor gene expression in human fetal lung in vitro.
  211. Vascular endothelial growth factor in human preterm lung.
  212. (1992). Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivo.
  213. (1995). Vascular endothelial growth factor mRNA increases in alveolar epithelial cells during recovery from oxygen injury.
  214. (1995). Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis.
  215. VEGF is deposited in the subepithelial matrix at the leading edge of branching airways and stimulates neovascularization in the murine embryonic lung.
  216. (2000). Vitamin A supplementation for preventing morbidity and mortality in very low birthweight infants. Cochrane Database Syst Rev
  217. (2000). What role does neutrophil apoptosis play in acute respiratory distress syndrome? Crit Care Med
  218. (1998). When do infants need additional inspired oxygen? A review of the current literature. Pediatr Pulmonol JT - Pediatric pulmonology.

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.